Patients go through a long ordeal of misdiagnosis, misunderstanding, ignorance, incomplete treatment recommendations and mental stress before they are diagnosed and receive treatment. We are breaking new ground in patient care and enabling early detection, well-founded information and daily support for lipedema.

The diagnosis of lipedema depends on the subjective assessment of the examiner, as there are no clear, measurable indications for the diagnosis. This lack of clarity leads to many misdiagnoses. With our AI technology, we are setting a new standard in the assessment of lipedema: objective, standardized and reproducible.

In order to alleviate symptoms and prevent them from worsening, it is necessary to use targeted therapies that are individually adapted to the patient's life and health situation. Our aim is to provide needs-based and personalized healthcare as early as possible in order to spare patients a path of suffering.

The data gap in lipedema research is large and hinders progress in researching the causes and treatment of the disease. The lack of comprehensive, high-quality data on lipedema not only impairs understanding, but also the development of effective therapeutic approaches or even cures. We collect anonymized data to gain new and valuable insights for basic and causal research on lipedema.